Boost in access to new treatments for psoriasis – Nursing Times
Boost in access to new treatments for psoriasisNursing TimesAccording to the new technology appraisal guidance, ustekinumab is recommended as an option, alone or in combination with methotrexate, for treating active psoriatic arthritis in adults only when treatment with tumour necrosis factor alpha inhibitors …and more »
[monetize id=”1″] [monetize id=”2″]
Psoriasis Homeopathy Treatment – Guttate Psoriasis Solutions
Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib … – PharmiWeb.com (press release)
European Pharmaceutical ReviewPfizer Announces 12 Presentations Including New Research Data on Tofacitinib …PharmiWeb.com (press release)A supplemental new drug application (sNDA) for tofacitinib 5 mg and 10 mg tablets is currently under review with the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are …AbbVie Presents Phase 3 Data Demonstrating Efficacy and Safety of HUMIRA …PR Newswire UK (press release)all 17 news articles »
https://www.dpsw.org/new-psoriasis-treatm…
